cannabidiol

Cannabidiol brand CbdMD Inc. (NYSE: YCBD) announced that net quarterly sales boosted 67% on a year-over-year basis, reaching $9.4 million. That's according to the company's second-quarter 2020 financial report. Another aspect that showed a significant increase was online direct to...

Cannabis companies are hustling to stay afloat and turn a profit just like every other business, but for Dr. Chanda Macias, the ramifications of the economic downturn are much more personal. Mothers like her rely on medicinal cannabis for treating their children's ailments. As CEO of...

NewLeaf Brands Inc. (CSE: NLB) (OTC: NLBIF) (FSE: 0NF), which makes the hemp-oil infused beverage TeaLief, has signed a letter of intent to purchase Mydecine Group, a company that specializes in medicinal mushroom and fungi. The purchase price is about $850,000. ...

A drug from GW Pharmaceuticals plc (NASDAQ: GWPH) targeting a cause of genetic epilepsy has received Priority Review status from the U.S. Food and Drug Administration.  The Cambridge, U.K.-based company and its subsidiary Greenwich Biosciences Inc. confirmed Tuesday...

GW Pharmaceuticals plc (NASDAQ: GWPH) said Friday it has submitted a Type II Variation Application to the European Medicines Agency, applying for authorization of its Epidyolex — Epidiolex in the U.S. — cannabidiol oral solution for the management of seizures related to tuberous...

Avicanna Inc (TSX: AVCN) announced Friday that its subsidiary, Santa Marta Golden Hemp S.A.S., exported its first batch of purified cannabidiol from Colombia to Canada for scientific research. To enable the import of CBD isolates into Canada, Health Canada issued three authorizations to...

By Bill Griffin The emerging European cannabidiol (CBD) market has been thrown into disarray since January 2019 over a change to CBD's classification by the European Food Safety Authority (EFSA). Here we look at what changed and explore options for those companies impacted. What changed? Before...

The Food and Drug Administration says it knows there’s demand for cannabis products, but says it's taking a “science-based” approach to determine their safety and efficacy as it considers how to handle their legality. What To Know The FDA recently opened a public docket on...

Cannabis has gained mainstream acceptance in recent years, but it's still federally banned in the U.S. That ban puts platforms like Facebook Inc. (NASDAQ: FB) in a difficult situation when it comes to cannabis advertising, and Facebook decided this week it will maintain its stance against...

On May 1, Level Brands Inc. changed its name and New York Stock Exchange ticker symbol from LEVB to cbdMD Industries (NYSE: YCBD). It's the first company in the CBD space to list on the U.S. stock exchange. The CBD company's leadership team and notable sports influencers — ...

Pet product sales continue to rise year over year. Spending figures reached $69.51 billion for pet products in 2017, up from $66.75 billion the year before, according to the American Pet Products Association. Of that, supplies and OTC medicine represented the third-largest sector for sales,...

The U.S. cannabidiol market should expect to see continued gains in the years ahead, according to Cowen. What Happened  The CBD market could represent a $16-billion opportunity by 2025, according to a report issued Monday by a team of Cowen analysts. The findings are based on a roughly 40...

Thinly-traded nano-cap OTC stock Life on Earth (OTC: LFER) surged Thursday after the company announced two CBD additions to its brand of calming drinks JustChill. What Happened Life on Earth said it will introduce two categories to its JustChill brand of beverages aimed to reduce stress and improve...

Hemp is often an overlooked subsector of the cannabis space, but its usage in the United States and around the world is growing every day. In fact, World Wrestling Entertainment, Inc. (NYSE: WWE) performer Daniel Bryan unveiled a brand new hemp version of the WWE Championship belt on Tuesday...

CBD, which is short for cannabidiol, is the second-most present ingredient in marijuana. It's not psychoactive, but is thought by many users to have medical benefits. On the business side, CBD is one of the fastest-growing segments. Hemp Business Journal estimates the CBD market will reach...